Skip to main content

Table 2 Summary of treatment

From: Primary breast double-hit lymphoma management and outcomes: a real-world multicentre experience

Treatment strategy PB-DHL, N (%)
Breast irradiation 31 (64.6)
 Sequence of breast irradiation  
  Breast irradiation with concurrent chemotherapy 11 (22.9)
  Breast irradiation following chemotherapy 20 (41.7)
 Chemotherapy protocol  
  R-HyperCVAD 16 (33.3)
  DA-EPOCH-R 18 (37.5)
  DA-EPOCH-R/MA 14 (29.2)
  ASCT 18 (37.5)
  1. PB-DHL primary breast double-hit lymphoma, R-HyperCVAD rituximab, hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone, alternating with cytarabine plus methotrexate, DA-EPOCH-R rituximab, dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, DA-EPOCH-R/MA rituximab, dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, alternating with high-dose methotrexate and cytarabine, ASCT autologous stem cell transplantation
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us